-
Mashup Score: 0
Explore the current issue of The Lancet Haematology, a monthly journal dedicated to publishing content that advocates change in, or illuminates, haematological clinical practice
Source: www.thelancet.comCategories: Hem/Onc News and Journals, Latest HeadlinesTweet
-
Mashup Score: 1Current and Emerging Management Strategies for Non-Transfusion-Dependent ß-Thalassemia - 2 year(s) ago
Dr Cappellini discusses current and emerging management approaches for patients with non-transfusion-dependent thalassemia (NTDT).
Source: MedscapeCategories: Hem/Onc News and Journals, Latest HeadlinesTweet
-
Mashup Score: 0Betibeglogene autotemcel receives FDA approval for patients with transfusion-dependent β-thalassemia - 2 year(s) ago
On August 17 2022, the US Food and Drug Administration (FDA) approved the first cell-based gene therapy, betibeglogene autotemcel (beti-cel),…
Source: VJHemOncCategories: Hem/Onc News and Journals, Latest HeadlinesTweet
-
Mashup Score: 1Betibeglogene autotemcel receives FDA approval for patients with transfusion-dependent β-thalassemia - 2 year(s) ago
On August 17 2022, the US Food and Drug Administration (FDA) approved the first cell-based gene therapy, betibeglogene autotemcel (beti-cel),…
Source: VJHemOncCategories: Hem/Onc News and Journals, Latest HeadlinesTweet
-
Mashup Score: 0Bluebird gene therapy approved by FDA for rare blood disease - 2 year(s) ago
The regulator cleared the biotech’s medicine Zynteglo for transfusion-dependent beta thalassemia, giving patients a powerful new treatment option. But it will come at a cost of $2.8 million in the U.S.
Source: BioPharma DiveCategories: Healthcare Professionals, Latest HeadlinesTweet
-
Mashup Score: 0Betibeglogene autotemcel receives FDA approval for patients with transfusion-dependent β-thalassemia - 2 year(s) ago
On August 17 2022, the US Food and Drug Administration (FDA) approved the first cell-based gene therapy, betibeglogene autotemcel (beti-cel),…
Source: VJHemOncCategories: Hem/Onc News and Journals, Latest HeadlinesTweet
-
Mashup Score: 3FDA Approves First Cell-Based Gene Therapy to Treat Adult and Pediatric Patients with Beta-thalassemia Who Require Regular Blood Transfusions - 2 year(s) ago
FDA approves Zynteglo (betibeglogene autotemcel)
Categories: Hem/Onc News and Journals, Latest HeadlinesTweet
-
Mashup Score: 0New Treatment Options in Paediatric Thalassemia - 2 year(s) ago
The third of our six-part series focuses on new treatment options in paediatric thalassemia with expert Dr Immacolata Tartaglione…
Source: European Medical JournalCategories: Hem/Onc News and Journals, Latest HeadlinesTweet
-
Mashup Score: 0National networking in rare diseases and reduction of cardiac burden in thalassemia major - 2 year(s) ago
AbstractAims. A tailored chelation therapy guided by magnetic resonance imaging (MRI) is a strategy to improve the prognosis in iron-loaded patients, in many ca
Source: OUP AcademicCategories: Cardiologists, Latest HeadlinesTweet
-
Mashup Score: 0SUMMARY - Eleventh Cooley's Anemia Symposium - 2 year(s) ago
Eleventh Cooley’s Anemia Symposium.
Source: events.nyas.orgCategories: Hematologists1, Latest HeadlinesTweet
Our October issue is out! Featuing trials in #pyruvatekinasedeficiency, #thalassemia, CLL #lymsm #leusm, #MDSsm, a cohort study on #CARTcell in infants and children, and more... Explore it here https://t.co/EyrqUdpO9D https://t.co/86MhqknS8J